Drew Deathe, MPH, is currently a Manager of Clinical Development in Cardiometabolic Health at Eli Lilly and Company, where they lead clinical development trials. Previously, Drew served as a Research Portfolio Manager at The Carter Center from 2019 to 2022 and worked as an Epidemiologist at IHRC, Inc. from 2018 to 2019. Drew's early experience includes roles as a Clinical Research Intern at Riley Hospital for Children and a Research Assistant at Indiana University School of Medicine. They earned a Master of Public Health in Global Health & Infectious Disease from Emory University and a Bachelor of Science in Health Sciences from Ball State University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices